Capturing the real-world benefit of residual ß-cell function during clinically important time-periods in established Type 1 diabetes.
Capturing the real-world benefit of residual ß-cell function during clinically important time-periods in established Type 1 diabetes. Diabet Med. 2022 05; 39(5):e14814.